- Forum actieveling
- Berichten: 278
- Lid geworden op: 06 Aug 2014 08:50
- waarderingen: 49
Guy2019 schreef:Amai,het management is idd goed bezig.19% eraf vandaag..Ik zou bijkopen Jimmy
Uw plaat draait door blijkbaar,.......en wie laatst lacht......
HEB $5.55 +1.09 +24.39%
Hemispherx Biopharma shares soar as reverse split takes effect
The biopharma is looking to strengthen its position as it moves forward with several studies of its flagship drug, ampligen
The 1-for-44 split has propelled the shares above the company's $5 target
Shares of Hemispherx Biopharma Inc (NYSEAMERICAN:HEB) were up sharply Tuesday in their first day of trading after a 1-for-44 reverse stock split.
The Florida-based company announced the move on May 31, anticipating that a split could help propel the stock to $5 per share.
That goal was reached — and then some — with the stock rising about 27.8% to $5.70 in afternoon trading on the NYSE American.
The biopharma is looking to strengthen its position as it moves forward with several studies of its flagship drug, ampligen, which the company says has shown progress in the treatment of breast and prostate cancers.
“We want a stock price high enough to allow all major players in the market, such as well-established funds, family offices, banks and index funds to buy on the open market and create favorable buying pressure on the stock,” said CEO Thomas Equels.
Gaan we vandaag voor de 7 of terug onder de 5???
Deelnemen aan het forum + meer functies?
Discussieer met duizenden beleggers, minder
advertenties, ideaal voor smartphone, betere
gebruikservaring en gratis abonneren op favoriete
onderwerpen. Registreer binnen enkele tellen